GLP1R, GIPR, Amylin R and GCGR Agonist/Antagonist (Confo Therapeutics)

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameGLP1R, GIPR, Amylin R and GCGR Agonist/Antagonist (Confo Therapeutics)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionGlucagon-like peptide 1 receptor modulatorsGlucose-Dependent Insulinotropic Polypeptide Receptor modulatorsAmylin receptor modulators +[4] 
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorAmylin Receptor +[4] 
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConfo Therapeutics NV
China Registration ClassN/A

Develop Information

Active CompaniesConfo Therapeutics NV
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A